Skip to main content

Master of Public Health

Subthalamic Nucleus Deep Brain Stimulation May Reduce Medication Costs in Early Stage Parkinson's Disease.

AUTHORS

Hacker ML , Currie AD , Molinari AL , Turchan M , Millan SM , Heusinkveld LE , Roach J , Konrad PE , Davis TL , Neimat JS , Phibbs FT , Hedera P , Byrne DW , Charles D , . Journal of Parkinson's disease. 2016 1 1; 6(1). 125-31

ABSTRACT

Subthalamic nucleus deep brain stimulation (STN-DBS) is well-known to reduce medication burden in advanced stage Parkinson’s disease (PD). Preliminary data from a prospective, single blind, controlled pilot trial demonstrated that early stage PD subjects treated with STN-DBS also required less medication than those treated with optimal drug therapy (ODT).

Subthalamic nucleus deep brain stimulation (STN-DBS) is well-known to reduce medication burden in advanced stage Parkinson’s disease (PD). Preliminary data from a prospective, single blind, controlled pilot trial demonstrated that early stage PD subjects treated with STN-DBS also required less medication than those treated with optimal drug therapy (ODT).

Tags: